Neurology

Mindfulness-based stress reduction (MBSR) could match the effectiveness of the commonly prescribed antidepressant escitalopram in treating anxiety disorders, according to the latest psychological stress news.

A new study examining the effects of antimicrobial exposure on Parkinson’s disease (PD) risk has revealed insights that could influence prescribing decisions, especially concerning antibiotics and antifungal medications.

Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.

Hippocampal functional connectivity may be an early indicator of chronic pain development in patients following whiplash and mild traumatic brain injuries (mTBIs) according to the results of a new study.

Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.

Prescribed drugs for diabetes may also reduce the risk of opioid overdoses and alcohol intoxication in patients struggling with addiction according to the results of a new study.

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.